Phase 2 trials granted for India’s first Covid nasal vaccine Lagatar24 Desk : The Department of Biotechnology has granted approval for phase 2 trials of India’s first Covid nasal vaccine, developed by Bharat biotech. Phase 1 trials have been conducted and completed on the age group of 18-60 years. “Bharat Biotech’s intranasal vaccine is the … Continue reading Phase 2 trials granted for India’s first Covid nasal vaccine